当前位置:首页 - 行情中心 - 冠昊生物(300238) - 财务分析

冠昊生物

(300238)

  

流通市值:40.17亿  总市值:40.17亿
流通股本:2.65亿   总股本:2.65亿

冠昊生物(300238)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润0.15亿元,每股收益0.06元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益48831.38万元,未分配利润-30672.79万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产76424.28万元,负债27592.90万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入94,797,135.39377,483,103.8278,135,520.4189,698,181.61
营业总成本76,040,276.86334,942,285.38249,921,949.86160,966,865.61
营业利润17,848,423.4228,243,591.4731,497,237.7126,056,317.79
利润总额19,106,612.7328,019,278.331,333,997.9525,878,411.96
净利润14,727,786.5516,607,493.4520,658,923.316,759,336.23
其他综合收益-16,948.9174,362.59-112,095.04-41,348.81
综合收益总额14,710,837.6416,681,856.0420,546,828.2616,717,987.42
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计282,432,258.91265,789,737.12273,614,308.84265,232,317.14
非流动资产合计481,810,551.95488,610,094.29456,705,730.69429,514,778.89
资产总计764,242,810.86754,399,831.41730,320,039.53694,747,096.03
流动负债合计145,955,381.56177,990,961.77164,287,752.35148,458,456.94
非流动负债合计129,973,588.16108,816,966.4294,958,477.3780,391,769.04
负债合计275,928,969.72286,807,928.19259,246,229.72228,850,225.98
归属于母公司股东权益合计557,207,253542,358,105.24546,408,981.61538,791,833.64
股东权益合计488,313,841.14467,591,903.22471,073,809.81465,896,870.05
负债和股东权益合计764,242,810.86754,399,831.41730,320,039.53694,747,096.03
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计107,890,735.24430,623,758.38323,070,746.17212,016,517.02
经营活动现金流出小计92,819,977.44381,068,961.39290,728,712.46177,237,462.78
经营活动产生的现金流量净额15,070,757.849,554,796.9932,342,033.7134,779,054.24
投资活动现金流入小计24,119.3598,550278,066.88138,970.36
投资活动现金流出小计24,933,790.4385,047,603.9660,133,403.0952,244,830.72
投资活动产生的现金流量净额-24,909,671.08-84,949,053.96-59,855,336.21-52,105,860.36
筹资活动现金流入小计30,101,30085,000,00072,000,00034,000,000
筹资活动现金流出小计2,865,911.6941,405,469.4336,214,956.1611,818,466.46
筹资活动产生的现金流量净额27,235,388.3143,594,530.5735,785,043.8422,181,533.54
汇率变动对现金及现金等价物的影响-25,515.77175,121.04-30,661.7461,941.5
现金及现金等价物净增加额17,370,959.268,375,394.648,241,079.64,916,668.92
期末现金及现金等价物余额121,854,759.37104,483,800.11104,349,485.07101,025,074.39
最新报告期:2025-04-25
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
西南证券杜向阳0.150.170.202025-04-25
TOP↑